EIKN · Eikon Therapeutics, Inc. · Exempt Offerings
Market Cap
$484.24M
Shares
54.17M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-02-28 | New | Biotechnology | $399,999,934 | $350,700,037 | 06b |
| 2023-06-01 | New | Biotechnology | $534,999,983 | $140,759,782 | 06b |
| 2022-01-06 | New | Biotechnology | $524,999,783 | $517,764,785 | 06b |
| 2021-05-13 | New | Biotechnology | $107,811,248 | $102,537,782 | 06b |
Showing 1–4 of 4 filings
Key facts
CIK
1861123
CUSIP
282564103
13F (30d)
33 filings
33 filers
Visit website
Investor relations